New international initiative to investigate the genetics of Parkinson’s
As part of the Aligning Science Across Parkinson’s (ASAP) initiative, an ambitious global five-year programme was announced today to understand the genetic root of Parkinson’s.
Results of phase 2 nilotinib study show no benefit
Results have been shared from the US-based phase 2 clinical trial of nilotinib in people with moderate to advanced Parkinson's.
While safe and tolerable, the repurposed drug did not appear to have beneficial effects.
The Parkinson’s Choir Christmas single
The Horsham and District local group is attempting to achieve big things with their 2019 single, ‘This Christmas Time’.
Progress in gene therapy treatment for Parkinson's
Researchers, funded by Parkinson's UK, have produced positive results in mice for a gene therapy treatment that directly targets the production of the alpha-synuclein protein.
New report shows people with advanced or terminal illness support law change on assisted dying
Survey we supported shares findings that people with advanced or terminal illness support a change in the law on assisted dying
Trustees' Week 2019: thank you to our trustees
This week is Trustees’ Week, an annual event to showcase the great work trustees do for charities up and down the UK.
Could sleep boost waste disposal in the brain and prevent Parkinson’s?
Alongside Alzheimer’s Research UK, we’re funding new research that will investigate whether boosting the brain’s self-cleaning system could be the key to new treatments.
Caution when looking at cell recycling in Parkinson’s
Researchers at the Oxford Parkinson’s Disease Centre have shown that cell recycling in Parkinson’s may play a more complex role than previously thought. These new results have been published in the journal of Cell Reports.
Scotland’s hospitals fail to give people with Parkinson’s medication on time more than 100,000 times each year
Media release outlining launch of new Get It On Time report for Scotland
Revolutionary research advocate Ken Bowler dies aged 76
The Parkinson’s community in Scotland, and beyond, has lost one of its giants with the passing of Professor Ken Bowler. Ken revolutionised the relationship between researchers and people living with Parkinson’s.